| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6735998
[patent_doc_number] => 20030013633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'USE OF MOLECULES THAT MODULATE AN ENERGY RELATED ASSOCIATED STATE'
[patent_app_type] => new
[patent_app_number] => 09/327199
[patent_app_country] => US
[patent_app_date] => 1999-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9067
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013633.pdf
[firstpage_image] =>[orig_patent_app_number] => 09327199
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/327199 | USE OF MOLECULES THAT MODULATE AN ENERGY RELATED ASSOCIATED STATE | Jun 6, 1999 | Abandoned |
Array
(
[id] => 4261564
[patent_doc_number] => 06258846
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Nutritional supplements'
[patent_app_type] => 1
[patent_app_number] => 9/323159
[patent_app_country] => US
[patent_app_date] => 1999-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9735
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258846.pdf
[firstpage_image] =>[orig_patent_app_number] => 323159
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/323159 | Nutritional supplements | May 31, 1999 | Issued |
| 09/321456 | METHODS OF PROMOTING OR ENHANCING INTERLEUKIN-12 PRODUCTION THROUGH ADMINISTRATION OF THALIDOMIDE | May 26, 1999 | Abandoned |
Array
(
[id] => 4323380
[patent_doc_number] => 06331560
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals'
[patent_app_type] => 1
[patent_app_number] => 9/318774
[patent_app_country] => US
[patent_app_date] => 1999-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7520
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 390
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331560.pdf
[firstpage_image] =>[orig_patent_app_number] => 318774
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/318774 | Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals | May 25, 1999 | Issued |
Array
(
[id] => 1508111
[patent_doc_number] => 06441027
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Method of regulating the female reproductive system through angiogenesis inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/313528
[patent_app_country] => US
[patent_app_date] => 1999-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 9
[patent_no_of_words] => 11674
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441027.pdf
[firstpage_image] =>[orig_patent_app_number] => 09313528
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/313528 | Method of regulating the female reproductive system through angiogenesis inhibitors | May 16, 1999 | Issued |
| 09/312168 | METHOD AND COMPOSITION FOR TREATING MAMMALIAN NASAL AND SINUS DISEASES CAUSED BY INFLAMMATORY RESPONSE | May 13, 1999 | Abandoned |
Array
(
[id] => 6892254
[patent_doc_number] => 20010018416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-30
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HEPATITIS-C'
[patent_app_type] => new
[patent_app_number] => 09/311497
[patent_app_country] => US
[patent_app_date] => 1999-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4431
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20010018416.pdf
[firstpage_image] =>[orig_patent_app_number] => 09311497
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/311497 | Compositions and methods for treating hepatitis-C | May 12, 1999 | Issued |
Array
(
[id] => 1521089
[patent_doc_number] => 06413970
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Pharmaceutical composition for treating viral diseases'
[patent_app_type] => B1
[patent_app_number] => 09/254548
[patent_app_country] => US
[patent_app_date] => 1999-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 3777
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413970.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254548
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254548 | Pharmaceutical composition for treating viral diseases | Apr 20, 1999 | Issued |
Array
(
[id] => 6033755
[patent_doc_number] => 20020019439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'THERAPEUTIC QUASSINOID PREPARATIONS WITH ANTINEOPLASTIC, ANTIVIRAL, AND HERBISTATIC ACTIVITY'
[patent_app_type] => new
[patent_app_number] => 09/293606
[patent_app_country] => US
[patent_app_date] => 1999-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9782
[patent_no_of_claims] => 120
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019439.pdf
[firstpage_image] =>[orig_patent_app_number] => 09293606
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/293606 | Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity | Apr 15, 1999 | Issued |
| 09/281893 | VIRAL TREATMENT | Mar 30, 1999 | Abandoned |
| 09/283356 | NOVEL FORMULATIONS COMPRISING LIPID-REGULATING AGENTS | Mar 30, 1999 | Abandoned |
| 09/281895 | METHOD OF PREVENTING VIRAL INFECTIONS | Mar 30, 1999 | Abandoned |
| 09/281115 | METHODS AND COMPOSITIONS FOR TREATING ALLERGIC AND RELATED DISORDERS USING FLUORINATED DESCARBOETHOXYLORATADINE | Mar 28, 1999 | Abandoned |
Array
(
[id] => 4329445
[patent_doc_number] => 06319951
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections'
[patent_app_type] => 1
[patent_app_number] => 9/117890
[patent_app_country] => US
[patent_app_date] => 1999-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5084
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/319/06319951.pdf
[firstpage_image] =>[orig_patent_app_number] => 117890
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/117890 | Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections | Mar 22, 1999 | Issued |
Array
(
[id] => 4155600
[patent_doc_number] => 06107303
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-22
[patent_title] => 'Treatment of Epstein Barr infection'
[patent_app_type] => 1
[patent_app_number] => 9/268889
[patent_app_country] => US
[patent_app_date] => 1999-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3435
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/107/06107303.pdf
[firstpage_image] =>[orig_patent_app_number] => 268889
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/268889 | Treatment of Epstein Barr infection | Mar 14, 1999 | Issued |
| 09/254701 | COMPOSITION COMPRISING AN ANTIVIRAL OR ANTIBACTERIAL AGENT FOR PREVENTING TRANSMISSION OF DISEASES | Mar 10, 1999 | Abandoned |
Array
(
[id] => 7636456
[patent_doc_number] => 06380201
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists'
[patent_app_type] => B1
[patent_app_number] => 09/262726
[patent_app_country] => US
[patent_app_date] => 1999-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65452
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/380/06380201.pdf
[firstpage_image] =>[orig_patent_app_number] => 09262726
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/262726 | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists | Mar 3, 1999 | Issued |
Array
(
[id] => 1420242
[patent_doc_number] => 06514979
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/261712
[patent_app_country] => US
[patent_app_date] => 1999-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10063
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514979.pdf
[firstpage_image] =>[orig_patent_app_number] => 09261712
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/261712 | Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor | Mar 2, 1999 | Issued |
Array
(
[id] => 4352584
[patent_doc_number] => 06291446
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Therapeutic treatment for cytomegalovirus infection'
[patent_app_type] => 1
[patent_app_number] => 9/253700
[patent_app_country] => US
[patent_app_date] => 1999-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5124
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291446.pdf
[firstpage_image] =>[orig_patent_app_number] => 253700
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/253700 | Therapeutic treatment for cytomegalovirus infection | Feb 21, 1999 | Issued |
| 09/242614 | VITAMINE PREPARATIONS FOR REDUCING OXYGEN CONSUMPTION DURING PHYSICAL EFFORTS | Feb 18, 1999 | Abandoned |